Skip to main content
Updating results

Pharmaceutical Manufacturing

  • Updated

WASHINGTON (AP) — It won’t speed the manufacture of vaccines. It enraged the developers who delivered lifesaving doses in record time. But President Joe Biden’s decision to support waiving intellectual property rights for coronavirus shots had a broader purpose: to broadcast his administration’s commitment to global leadership.

  • Updated

WASHINGTON (AP) — It won’t speed the manufacture of vaccines. It enraged the developers who delivered lifesaving doses in record time. But President Joe Biden’s decision to support waiving intellectual property rights for coronavirus shots had a broader purpose: to broadcast his administration’s commitment to global leadership.

  • Updated

GENEVA (AP) — European leaders voiced increasing skepticism Friday that a U.S. proposal to lift patent protections on COVID-19 vaccines would solve the problem of getting shots into the arms of people in poorer countries, with some instead calling for more exports of the doses already being produced.

  • Updated

GENEVA (AP) — Several world leaders Thursday praised the U.S. call to remove patent protections on COVID-19 vaccines to help poor countries obtain shots. But the proposal faces a multitude of hurdles, including resistance from the pharmaceutical industry.

  • Updated

NEW DELHI (AP) — Under order by the Supreme Court, India's government on Thursday agreed to provide more medical oxygen to hospitals in the capital city of New Delhi, potentially easing a 2-week-old shortage that worsened the country's exploding coronavirus crisis.

  • Updated

ROME (AP) — The CEOs of vaccine-makers Pfizer and Moderna joined cardinals, academics and the lead guitarist of Aerosmith in opening a unique Vatican conference on COVID-19, other global health threats and how science, solidarity and spirituality can address them.

  • Updated

As much as Bill and Melinda Gates might want to keep their pending divorce private, the split between the billionaire co-founders of the world’s largest private foundation is sure to have very public consequences, with the breakup having already sent a wave of anxious uncertainty through the worlds of philanthropy and community health.

  • Updated

GENEVA (AP) — U.S. biotech company Moderna will provide up to 500 million doses for the U.N.-backed program to ship coronavirus vaccines to needy people in low- and middle-income countries, but shipments won't begin until the fourth quarter, the company and program leaders said Monday.

  • Updated

WASHINGTON (AP) — The U.S. Food and Drug Administration is expected to authorize Pfizer's COVID-19 vaccine for youngsters ages 12 to 15 by next week, according to a federal official and a person familiar with the process, setting up shots for many before the beginning of the next school year.

Get up-to-the-minute news sent straight to your device.

Topics

Breaking News

News Alert